A Chinese surgeon remotely operated a robotic system to remove a prostate tumor from a patient 220 kilometers away. Utilizing ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

There will be approximately 299,010 new cases of prostate cancer diagnosed in 2024, according to the American Cancer Society. Treatments vary, including chemotherapy, hormone therapy, ablative therapy ...

Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, after ...

Johnson & Johnson’s PROTEUS Phase 3 trial shows apalutamide + hormone therapy before/after surgery improves outcomes in ...

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients. Prostate cancer treatment continues to evolve, and ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

OhhMed Medical Ltd., a pioneering medical technology firm specialising in male urology, today announced the initiation of a ...

Original Medicare (parts A and B) covers medically necessary prostate surgeries, including treatments for an enlarged prostate and prostate cancer. Medicare covers various prostate procedures, ...